RSV usually only has mild symptoms, but it can lead to breathing problems in the most vulnerable infants. The vaccine is offered to prevent babies contracting the virus in the first six months of ...

The CDC expanded RSV vaccine recommendations to include adults aged 50 and above who have underlying health conditions ...

U.S. FDA has informed Moderna that due to administrative constraints, the agency will not complete its review of mRNA-1345 by the PDUFA date of May 12, 2024 Agency has indicated it expects to ...

In its news release, Moderna said its mRNA vaccine is the first RSV shot to come in a pre-filled syringe and says that will save time for health-care workers and reduce any errors in administering it.

In its news release, Moderna said its mRNA vaccine is the first RSV shot to come in a pre-filled syringe and says that will save time for health-care workers and reduce any errors in administering it.

MRNA's second-quarter results are likely to spotlight a sharp decline in Spikevax sales, RSV uptake and key pipeline ...

Moderna’s shot is the third RSV vaccine for people 60 and older that’s gotten the green light from the FDA and the first mRNA vaccine among them. It’s the company’s second product to receive FDA ...

TORONTO - Health Canada has approved Moderna's mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older — but it won't be available until next year, ...